109 related articles for article (PubMed ID: 24846674)
1. Aberrant expression of neuroendocrine markers in angiosarcoma: a potential diagnostic pitfall.
Tessier Cloutier B; Costa FD; Tazelaar HD; Folpe AL
Hum Pathol; 2014 Aug; 45(8):1618-24. PubMed ID: 24846674
[TBL] [Abstract][Full Text] [Related]
2. Aberrant expression of epithelial and neuroendocrine markers in alveolar rhabdomyosarcoma: a potentially serious diagnostic pitfall.
Bahrami A; Gown AM; Baird GS; Hicks MJ; Folpe AL
Mod Pathol; 2008 Jul; 21(7):795-806. PubMed ID: 18487991
[TBL] [Abstract][Full Text] [Related]
3. Neuroendocrine differentiation in head and neck squamous cell carcinoma.
Schartinger VH; Falkeis C; Laimer K; Sprinzl GM; Riechelmann H; Rasse M; Virgolini I; Dudás J
J Laryngol Otol; 2012 Dec; 126(12):1261-70. PubMed ID: 23050666
[TBL] [Abstract][Full Text] [Related]
4. Primary sclerosing neuroendocrine carcinomas of the lung: A clinicopathologic and immunohistochemical study of 10 cases.
Kalhor N; Suster S; Moran CA
Am J Clin Pathol; 2010 Apr; 133(4):618-22. PubMed ID: 20231615
[TBL] [Abstract][Full Text] [Related]
5. Neuroendocrine tissue-specific transcription factor, BETA2/NeuroD, in gastric carcinomas: a comparison with chromogranin A and synaptophysin expressions.
Fujii A; Kamiakito T; Takayashiki N; Fujii T; Tanaka A
Pathol Res Pract; 2003; 199(8):513-9. PubMed ID: 14533935
[TBL] [Abstract][Full Text] [Related]
6. Unusual Neuroendocrine Differentiation in a Small Round Cell Angiosarcoma: A Potential Histologic Mimicker of Superficial Ewing Sarcoma.
Machado I; Santonja C; Huerta V; Cruz J; Requena C; Requena L; Llombart-Bosch A
Am J Dermatopathol; 2018 Sep; 40(9):671-675. PubMed ID: 29533277
[TBL] [Abstract][Full Text] [Related]
7. Angiosarcoma of the lung: 2 cases report and literature reviewed.
Chen YB; Guo LC; Yang L; Feng W; Zhang XQ; Ling CH; Ji C; Huang JA
Lung Cancer; 2010 Dec; 70(3):352-6. PubMed ID: 20952087
[TBL] [Abstract][Full Text] [Related]
8. Transcription factor ERG is a specific and sensitive diagnostic marker for hepatic angiosarcoma.
Wang ZB; Yuan J; Chen W; Wei LX
World J Gastroenterol; 2014 Apr; 20(13):3672-9. PubMed ID: 24707153
[TBL] [Abstract][Full Text] [Related]
9. An immunohistochemical study of cervical neuroendocrine carcinomas: Neoplasms that are commonly TTF1 positive and which may express CK20 and P63.
McCluggage WG; Kennedy K; Busam KJ
Am J Surg Pathol; 2010 Apr; 34(4):525-32. PubMed ID: 20182342
[TBL] [Abstract][Full Text] [Related]
10. The clinical significance of neuroendocrine differentiation in T3-T4 node-negative colorectal cancer.
Cho YB; Yang SS; Lee WY; Song SY; Kim SH; Shin HJ; Yun SH; Chun HK
Int J Surg Pathol; 2010 Jun; 18(3):201-6. PubMed ID: 19372085
[TBL] [Abstract][Full Text] [Related]
11. Chromogranin A, neuron-specific enolase and synaptophysin as neuroendocrine cell markers in the diagnosis of tumours of the gastro-entero-pancreatic system.
Schürmann G; Betzler M; Buhr HJ
Eur J Surg Oncol; 1990 Aug; 16(4):298-303. PubMed ID: 2116326
[TBL] [Abstract][Full Text] [Related]
12. Immunoreactivity for epithelial and neuroendocrine antibodies are useful in the differential diagnosis of lung carcinomas.
Lyda MH; Weiss LM
Hum Pathol; 2000 Aug; 31(8):980-7. PubMed ID: 10987260
[TBL] [Abstract][Full Text] [Related]
13. Neuroendocrine differentiation in extrahepatic bile duct carcinomas and its prognostic significance.
Hong SM; Kim MJ; Pi DY; Jo D; Yu E; Ro JY
Hum Pathol; 2005 Jul; 36(7):732-40. PubMed ID: 16084941
[TBL] [Abstract][Full Text] [Related]
14. Chromogranin A-, serotonin-, synaptophysin- and vascular endothelial growth factor-positive endocrine cells and the prognosis of colorectal cancer: an immunohistochemical and ultrastructural study.
Gulubova M; Vlaykova T
J Gastroenterol Hepatol; 2008 Oct; 23(10):1574-85. PubMed ID: 18771509
[TBL] [Abstract][Full Text] [Related]
15. [Analysis of clinicopathological features of intestinal neuroendocrine neoplasms].
Gao W; Liu SM; Lu HZ; Liang J; Yuan YL; Liu XY
Zhonghua Zhong Liu Za Zhi; 2012 Jun; 34(6):450-6. PubMed ID: 22967448
[TBL] [Abstract][Full Text] [Related]
16. A comparison of synaptophysin, chromogranin, and L-dopa decarboxylase as markers for neuroendocrine differentiation in lung cancer cell lines.
Jensen SM; Gazdar AF; Cuttitta F; Russell EK; Linnoila RI
Cancer Res; 1990 Sep; 50(18):6068-74. PubMed ID: 2168288
[TBL] [Abstract][Full Text] [Related]
17. [Primary hepatic angiosarcoma: a clinical and pathological analysis].
Wang ZB; Wei LX
Zhonghua Bing Li Xue Za Zhi; 2013 Jun; 42(6):376-80. PubMed ID: 24060070
[TBL] [Abstract][Full Text] [Related]
18. Solid neuroendocrine carcinoma of the breast.
Abbasi NZ; Zahur Z; Sheikh AS; Khan AA; Ali F; Memon KH; Moizuddin SS; Loya A; Barkat N
J Coll Physicians Surg Pak; 2013 Nov; 23(10):820-2. PubMed ID: 24169396
[TBL] [Abstract][Full Text] [Related]
19. The prognostic significance of neuroendocrine markers and somatostatin receptor 2 in hepatocellular carcinoma.
Murakami K; Kumata H; Miyagi S; Kamei T; Sasano H
Pathol Int; 2021 Oct; 71(10):682-691. PubMed ID: 34320691
[TBL] [Abstract][Full Text] [Related]
20. A comparison of NSP-reticulons with conventional neuroendocrine markers in immunophenotyping of lung cancers.
Senden NH; Timmer ED; de Bruïne A; Wagenaar SS; Van de Velde HJ; Roebroek AJ; Van de Ven WJ; Broers JL; Ramaekers FC
J Pathol; 1997 May; 182(1):13-21. PubMed ID: 9227337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]